Philips Files 6-K Report
Ticker: RYLPF · Form: 6-K · Filed: Aug 30, 2024 · CIK: 313216
Sentiment: neutral
Topics: reporting, foreign-issuer
TL;DR
Philips filed a routine 6-K, no major news here.
AI Summary
Koninklijke Philips NV filed a Form 6-K on August 30, 2024, reporting as a foreign issuer. The filing does not contain specific financial figures or operational updates but serves as a notification to the SEC.
Why It Matters
This filing indicates that Koninklijke Philips NV is fulfilling its reporting obligations as a foreign issuer with the SEC, which is standard practice for companies with publicly traded securities in the US.
Risk Assessment
Risk Level: low — This filing is a standard procedural document and does not contain new material information that would typically impact stock price or indicate significant risk.
Key Players & Entities
- KONINKLIJKE PHILIPS NV (company) — Filer
- Royal Philips (company) — Registrant's name in English
- The Netherlands (company) — Jurisdiction of incorporation
- Breitner Center, Amstelplein 2, 1096 BC Amsterdam, The Netherlands (company) — Principal executive offices address
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required by the SEC that is generally used to furnish or report information which the issuer would be required to make public pursuant to the laws of its home country or which it may otherwise make or has made or may be required to make public.
What is the filing date of this 6-K report?
The filing date of this 6-K report is August 30, 2024.
Is Koninklijke Philips NV required to file Form 20-F?
Yes, the filing indicates that the registrant files annual reports under cover of Form 20-F.
What is the SIC code for Koninklijke Philips NV?
The Standard Industrial Classification (SIC) code for Koninklijke Philips NV is 3844, which corresponds to X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS.
Does this filing contain specific financial results?
No, this Form 6-K filing does not appear to contain specific financial results or operational updates; it is a report of foreign issuer status.
Filing Stats: 529 words · 2 min read · ~2 pages · Grade level 11.1 · Accepted 2024-08-30 08:14:29
Filing Documents
- phg-20240830.htm (6-K) — 10KB
- visual0001.jpg (GRAPHIC) — 93KB
- visual0002.jpg (GRAPHIC) — 77KB
- 0000313216-24-000016.txt ( ) — 230KB
From the Filing
Philips - 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 August 30, 2024 KONINKLIJKE PHILIPS N.V. (Exact name of registrant as specified in its charter) Royal Philips (Translation of registrant’s name into English) The Netherlands (Jurisdiction of incorporation or organization) Breitner Center, Amstelplein 2, 1096 BC Amsterdam, The Netherlands (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F ☒ Form 40-F ☐ Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule101(b)(1): ☐ Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule101(b)(7): ☐ Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes ☐ No ☒ Name and address of person authorized to receive notices and communications from the Securities and Exchange Commission: M.J. van Ginneken Koninklijke Philips N.V. Amstelplein 2 1096 BC Amsterdam – The Netherlands This report comprises a copy of the following press release: “ Periodic update on transaction details related to Philips’ share repurchases ", dated August 30, 2024 . Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf, by the undersigned, thereunto duly authorized at Amsterdam, on August 30, 2024. KONINKLIJKE PHILIPS N.V. /s/ M.J. van Ginneken (Chief Legal Officer) Press information August 30, 2024 Periodic update on transaction details related to Philips’ share repurchases Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today reported that in the period from August 23, 2024 up to and including August 29, 2024 a total of 1,262,739 of its own common shares were repurchased, with a weighted average purchase price of EUR 27.24. These repurchases were made under the repurchase program to cover certain of the company’s obligations arising from its long-term incentive plans, which was announced on August 5, 2024. Further details can be found via this link. For further information, please contact: Elco van Groningen Philips External Relations Tel.: +31 6 8103 9584 E-mail: elco.van.groningen@philips.com Dorin Danu Philips Investor Relations Tel.: +31 20 59 77055 E-mail: dorin.danu@philips.com About Royal Philips Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring, and enterprise informatics, as well as in personal health. Philips generated 2023 sales of EUR 18.2 billion and employs approximately 68,700 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.